Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s displayed software revision has been updated to the next release (from v3.5.2 to v3.5.3), indicating a backend/site version change rather than an update to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-23T21:57:18.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T12:22:11.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added revision label v3.5.0. Removed revision label v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:41:27.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:32:45.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the prior notice about government funding lapse and NIH operating status was removed (associated with Revision: v3.4.1).
    Difference
    0.5%
    Check dated 2026-02-11T05:14:52.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Banner notice informs users about a lapse in government funding and that the NIH Clinical Center is open, with status updates available at opm.gov. Site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T04:58:49.000Z thumbnail image

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.